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Nonspecific mitogens have provided valuable data  regarding the  mechanism of 
lymphocyte activation and cellular cooperation. Studies of the activation of murine 
lymphocytes by mitogens have shown that phytohemagglutinin  (PHA)1 and  concanava- 
lin A  (Con A)  are able to stimulate murine thymus-derived (T)  cells but not bone 
marrow-derived (B)  cells, whereas bacterial lipopolysaccharide (LPS) activated only 
B cells (1-3). The selective activation of lymphocytes by mitogens is not determined 
by the specific adherence of these materials to only B or T  cells, since their binding 
has been shown to be nonspecific (4-6). In addition, the usual T-cell activation seen 
with PHA or Con A can be altered, allowing B-cell activation, when the molecular 
characteristics of  these  mitogens are  changed by complexing them  to an insoluble 
matrix such as sepharose (5, 7). This implies that the molecular structure of a mitogen 
is significant  in the induction of B-cell activation. In this regard, it is of note that the 
B-cell activation with LPS has been ascribed to its unusual molecular structure (8, 9). 
Certain other observations support the concept that the physical properties of  the 
stimulant  are also important for B-cell activation leading to antibody formation. Thus, 
B cells are stimulated to form specific antibody by thymic-independent  antigens such 
as LPS (10, 11), polyvinylpyrrolidone  (PVP) (10), pneumococcal polysaccharide (SSS 
III) (12, 13), polymerized flagellin (POL)  (14, 15), and the synthetic double-stranded 
RNA, polyinosinic-polycytidylic  acid (poly I-C) (16, 17). These antigens are all char- 
acterized by a polymeric structure with repeating antigenic determinants. 
* Supported by the Bureau of Medicine and Surgery Work Unit no. MR041.02.01.0020- 
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1  Abbreviations used in this paper: Con A, concanavalin A; FC S, fetal calf serum; LPS, bac- 
terial lipopolysaccharide; LT, lymphotoxin; NRS, normal rabbit sera; PHA, phytohemagglu- 
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Poly I. C has been shown to share many of the biologic actions of LPS. Both 
induce interferon production (18, 19), are pyrogenic (20) and toxic (21, 22), and 
both poly I. C  and LPS act as potent immunological adjuvants (8, 23, 24). In 
addition, poly I. C has been shown to stimulate proliferation of murine lymphoid 
cells in vitro and in vivo (25, 26); however, these studies did not show whether 
poly I. C  activated T  cells or  B  cells. The characterization of poly I. C  as  a 
mitogen is of considerable importance to the understanding  of the mechanism of 
cell activation. Thus, if poly I. C was able to act as a B-cell mitogen, this would 
support  the  concept  that  it  is  not  the  nature  of  the  determinants but  the 
unique polymeric presentation of the determinants of thymic-independent  anti- 
gens that trigger B-cell activation. 
In this communication we have examined the  specificity of poly I-C  as  a 
mitogen. We  have  shown  that  the  double-stranded polynucleotide poly  I. C 
and the  single-stranded polynucleotides poly I  and poly C  are  specific B-cell 
mitogens. 
Materials and Methods 
Animals.--DBA/2N  mice originally derived  from those  of  the  National  Institutes of 
Health,  Bethesda,  Md.  were inbred  in our  laboratory.  C57B1/10J, C57Bl/6J,  C3H/HeJ, 
BALB/cJ, CBA/J, and B 10.D2/J mice were obtained from Jackson Laboratory, Bar Harbor, 
Maine. Nude mice (Nu/Nu) were obtained from the National Institutes of Health. Groups of 
C3H/HeJ mice were thymectomized at birth or at 6 wk of age by aspiration through a sternum- 
splitting incision; littermates were sham operated. Thymectomized mice were irradiated  (800 
R) 7 days after surgery. They were reconstituted after irradiation with 20 X  106 syngeneic 
bone marrow cells that had been treated with AKR anti-theta C3H (anti-0) serum (see anti- 
sera treatment of spleen cells for further details). All mice were sacrificed  at 8-12 wk of age. 
Mitogens and Culture Media.--RPMI  1640 (Grand Island Biological Co., Grand Island, 
N.Y.) with N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid buffer (25 mM) was used 
throughout the experiments. Before use, penicillin (100 U/ml), streptomycin (100  #g/ml), and 
L-glutamine (200 raM) were added. Polyinosinic acid (poly I), polycytidylic acid (poly C), and 
poly I.C were obtained from P. L.  Biochemicals, Inc.  (Milwaukee, Wis.; lot nos. 200-15, 
191-15, and 247231, respectively). The poly I.C used in these experiments was complexed by 
P. L.  Biochemicals, Inc. from the same lots of single-stranded nucleic acids used in these 
studies. Using aseptic technique, they were dissolved in supplemented RPMI 1640 at a final 
concentration of 1 mg/ml and stored at  --20°C as stock solutions. Cultures of the poly I, 
poly C, and poly I. C, as shipped from P. L. Biochemicals,  Inc., were inoculated in thioglycolate 
broth and incubated for 72 h at 37°C to verify their sterility. 
The mitogens employed in these experiments were used at levels determined by preliminary 
experiments that gave optimum stimulation with mouse spleen cells. All the mitogens were 
diluted in RPMI 1640 stock solution and stored at --20°C until used. Phytohemagglutinin-P 
(PHA-P) (Difco Laboratories, Inc., Detroit, Mich.) was used at 0.05%; bacterial ]ipopolysac- 
charide Escherlchla coli 0111 :B4 (LPS) (Difco) was used at a concentration of 50 #g/ml; and 
coneanavalin A (Con A) (Calbiochem, San Diego, Calif.) was used at a concentration of 1.25 
/~g/ml. 
Cell Suspensions.--Mice  were killed by cervical dislocation and spleens removed using 
aseptic technique. Spleen cells were obtained by gentle teasing with a rubber policeman. Cell 
aggregates were then dispersed by passing them through  a 26 gauge needle, and single-cell 
suspensions were washed twice with media. Histological study of blastogenic transformation SCHER~  STRONG~ AHMED~ KNUDSEN~ AND  SELL  1547 
induced by poly I, poly C, and poly I.. C was studied by staining smears of cell suspensions 
(25  X  106 cells/ml) with Wright's Giemsa stain. Primitive cells were identified by their loose 
chromatin staining, large nucleolus, and size greater than 15/zm. Cell suspensions  were incu- 
bated with 250 #g/ml of the polynucleotides  for 48 h before staining and 500 mononuclear cells 
were counted to express an index of blastogenesis. 
Spleen  Cell Cultures.--Cultures  were set up in sterile tissue culture microtiter plates (no. 
3040; Falcon Plastics, Div. of BioQuest, Oxnard, Calif.)  (27). Briefly, 100 #1 of 8 X  10 e spleen 
cells/ml in media was added to each microculture well. In addition, 50 #1 of 20% heat-inacti- 
vated (56°C, 30 min) fetal calf serum (FCS) (Grand Island Biological Co.) in media, and 50 #1 
of media alone or media containing the mitogen being studied were added. Each well contained 
a total of 800,000 spleen cells in a total volume of 200 #I with 5% FCS final concentration. The 
microtiter plates, covered with sterile raised lids (Linbro no. 55; Bellco Glass, Inc., Vineland, 
N.J.), were cultured for the appropriate lengths of time in a humidified atmosphere of 95% air, 
5% CO2 at 37°C.  18 h before harvesting, 20 #1 of media containing 1 #Ci of [methyl-3H]thymi - 
dine  ([~H]TdR)  1.9  Ci/mM  (Schwarz/Mann, Orangeburg, N.Y.)  was added to each well. 
Unless otherwise noted, the cultures were harvested at 48  h  using the multiple automated 
sample harvester (MASH), described in previous reports (27). Samples were then transferred 
to  1-dram vials and 3 ml of scintillation fuid, toluene containing Liquifluor (New England 
Nuclear, Boston, Mass.), was added. The samples were counted in a Beckman Model L-S 250 
liquid scintillation counter. Data were analyzed using a Wang 700C program calculator. The 
final data, counts per minute (cpm), are reported as the mean of triplicate samples, plus or 
minus the standard error (+SE). 
Antisera.--Rabbit  anti-poly I.C was a gift of Dr. L. Parker of the National Institutes of 
Health. It was prepared by immunization of New Zealand White rabbits with a complex of 
100 #g of poly I.C and  100 #g of methylated bovine gamma globulin, emulsified  with an 
equal volume of complete Freund's adjuvant  (28). Rabbit anti-lipid A was a gift of Dr. W. 
Grace of the National Naval  Medical Center and was prepared by immunization of New 
Zealand White rabbits with a pure preparation of lipid A complexed to bovine serum albumin 
and emulsified with an equal volume of complete Freund's adjuvant. Rabbit anti-MBLA sera 
(anti-MBLA) was prepared according to the method of Raft (29), and AKR anti-theta C3H 
sera (anti-0) was prepared according to the method of Reif and Allen (30). All antisera were 
inactivated at 56°C for 30 min. The anti-lipid A and anti-poly I. C were absorbed by three 
incubations at 37°C for 30 mill with an equal volume of mouse liver powder. 
Antisera  Treatment  of Cell Populatlons.--Spleen  cells  (25  X  106) were incubated with 0.1 
ml of anti-0 sera or 0.2 ml of anti-MBLA at 37°C for 30 min to a final volume of 1 ml in me- 
dia. Controls consisted of normal AKR mouse sera or normal rabbit sera (NRS) that had been 
similarly heat inactivated and absorbed with mouse liver powder. After the initial incubation, 
0.2 ml of NRS, which had been shown to be not cytotoxic to mouse spleen cells, was added as 
a source of complement, and the cells were incubated at 37°C  for an  additional 30 rain. Vi- 
able cells were recovered from cellular debris by layering the treated cells, suspended in 2 ml 
of media, over a 7 ml Ficoll-Hypaque gradient (sp gr 1.099). The layered cells were centrifuged 
at 450 g for 40 rain. The cells at the interface were recovered, washed twice, and resuspended 
at 8  X  106 cells/ml. 
Treatment  of Mitogens  w~th Antisera.--In  order to determine if the mitogenicity observed 
with poly I-C was due to LPS contamination, LPS and poly I.C at different concentrations 
were incubated with either anti-lipid A antibody or anti-poly I. C antibody in media in a total 
volume of 0.6 ml for 1 h at 37°C followed  by 4°C for 18 h. The tubes were then spun in an 
ultracentrifuge (Damon/IEC, motor head A-321) at  150,000 g for 1 h, and the supernatant 
fluid was passed through a 0.22 #m Swinnex filter and assayed for mitogen activity. Control 
tubes containing NRS were run in parallel. 
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containing  10% FCS. To this was added an equal volume of media containing 0.1% PHA-P, 
25 #g/ml Con A, 100/~g/ml LPS, and 500 #g/ml poly I. C, or media containing no mitogen 
to a total final volume of 5 ml. The cells were incubated for 4 days at 37°C in a 5% CO 2 hu- 
midified atmosphere.  Supernatant fluids were obtained by centrifugation of the cultures at 
800 g for 15 mill. The supernatant fluids were dialyzed in media using a minicon-B  (B-10) 
clinical sample concentrator (Amicon Corp., Lexington, Mass.). Samples were stored at -- 20°C 
until used. 
Lymphotoxin (LT) was assayed by a recently developed microassay procedurefl Mouse L- 
929 cells were maintained and used in media containing 10% FCS and 2.5 #g per ml Ampho- 
tericin B (Grand Island Biological Co.). Monolayers of L cells were detached by trypsinization, 
suspended in media, counted,  and diluted to 20,000 L cells/ml. 50 #1 of L  cells (1,000 cells) 
was added to each well of a microtiter plate using a  Hamilton microsyringe fitted with a re- 
peating dispenser. After allowing the L cells to attach for 3-4 h, 50 #1 of twofold serial dilutions 
of the spleen cell supernatant fluids was added to triplicate cultures. The plates were incubated 
for a total of 96 h and 24 h before harvesting 1/~Ci of [3H]thymidine was added to each well as 
noted before. The harvesting procedure consisted of removing the media from each well by 
aspiration using a 20 ml syringe fitted with a 26 gauge needle. To each well was added 50 #l of 
a 0.5% solution of trypsin 1:200 (Difco Laboratories) and plates were incubated at 37°C for 
15 min. Cells in each well were harvested  and counted for [~H]thymidine as previously de- 
scribed. Data are presented as the dilution that shows 50% inhibition of growth of L cells 
(IDs0)  when mitogen-stimulated or unstimulated lymphocyte supernatant fluids were com- 
pared with control wells containing only media. 
RESULTS 
Thymidine Incorporation Induced by Poly I, Poly C, and Poly I.C.--In a 
previous study using murine spleen cells, poly I. C was shown to be a mitogen at 
10,  25,  and 50/zg/ml  (26). In order to study the response to poly I. C  in the 
microculture system, female DBA/2N  and  C3H/HeJ  mouse spleen cells were 
incubated with varying concentrations of poly I. C for 48  h  as shown in Fig. 1. 
In the spleen cells from the C3H/HeJ strain, there were only minor increases in 
the  thymidine incorporation with  concentrations  of poly I. C  greater  than  5 
#g/ml. The spleen cells from the DBA/2N strain showed a gradual increase in 
incorporation that reached a  plateau at 250 ~g/ml of poly I. C. Increasing the 
number of DBA/2N  cells from  200,000  to 800,000  per culture caused a  linear 
increase in responsiveness to poly I- C  (Fig. 2). All further studies were carried 
out with 800,000 cells per culture unless indicated. 
It has been noted  (25)  that the single-stranded polynucleotides, poly I  and 
poly C, when given in vivo at 200/zg daily for 3 days, did not cause an increase 
in the percentage of primitive lymphoid cells in blood films. Under similar condi- 
tions, poly I. C  caused 30%  of the lymphoid cells to appear as primitive cells. 
These findings suggested that poly I  and poly C might not stimulate thymidine 
incorporation in vitro. For this reason and to help define the possibility of LPS 
contamination of poly I. C  (which was prepared from the single-stranded poly I 
and poly C), cultures were set up using poly I, poly C, and poly I. C  at 5, 50, 
2 Knudsen,  R. C., A. Ahmed, and K. W. Sell. 1973. A microassay for lymphotoxin using 
microtiter plates and a multiple automated sample harvester. Manuscript in preparation. 1549 
50 
250, and 500/~g/ml for 48 h (Fig. 3). Poly I  and poly C both were mitogenic at 
all concentrations from, 5 to 500/zg/ml, and poly I  was mor~ stimulatory than 
poly I. C at all concentrations studied with a maximum at 250/~g/ml. Poly C 
was less stimulatory than poly I. C at the concentrations studied. In efforts to 
determine the optimum incubation time, 250/zg/ml of poly I. C was incubated 
with DBA/2N spleen cells for 24, 48, 72, and 96 h. As shown in Fig. 4, mitogenic 
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FIG. 1. The uptake of [3H]TdR by C3H/HeJ  (O--O) and DBA 2N (A--A) spleen cells 
(800,000 cells/culture) in response  to varying concentrations  of poly I.C at 48 h. 
activity was seen as early as 24 h and continued up to 96 h with the maximum 
activity at 48 and 72 h. 
The ability of these polynucleotides to  stimulate  thymidine incorporation 
paralleled  their  ability  to  transform  murine  spleen  cells  as  determined  by 
histologic examination. Thus, poly I  transformed 33.6%  of the mononuclear 
cells,  whereas poly I-C and poly C transformed 20.4 and 18.6%, respectively. 
The response to LPS was in the same range at 24.4%, and control cultures had 
6 % primitive cells. 1550  B-CELL  ACTIVATION BY  POLYNUCLEOTIDES 
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FIG. 2. The uptake of [3H]TdR  by varying numbers of DBA/2N spleen cells in response  to 
250 #g/ml  of poly I-C  cultured for 48  h.  (Control culture, O--O; poly I-C  culture, 
o--o.) 
Demonstration of the Lack of Contamination of Poly I. C with LPS.--The syn- 
thetic polyribonucleic acids are prepared with a Micrococcus lysodeikticus poly- 
nucleotide phosphorylase. In view of the enzyme source and the ability of these 
polynucleotides to stimulate  mouse cells,  we were concerned that  they were 
contaminated with LPS. In order to study this problem, antisera obtained from 
rabbits immunized against lipid A or poly I. C were used to determine if they 
would inhibit the mitogenicity of LPS and/or poly I. C. 
When  anti-lipid A  antibody was incubated with varying concentrations of 
LPS and then ultracentrifuged, the supernatant fluids, when tested for mito- 
genicity,  gave  approximately 5,000  cpm  of  [3H]TdR incorporation,  as  com- 
pared with 44,357  to 69,120 cpm for the NRS-treated controls (Fig. 5 a). Treat- 
ment of LPS with anti-poly I. C antibody did not alter its mitogenicity when 
compared with LPS treated with NRS. When anti-poly I. C antibody was used 
to treat poly I. C, however, there was a marked reduction in the mitogenic re- 
sponse (Fig. 5 b). Finally, and most important, anti-lipid A antibody treatment 
did not alter the mitogenicity of poly I. C. 
Strain Differences in the Response to Poly I, Poly C, and Poly I-C.--Dean, 
Wallen,  and Lucas (26)  reported that  while CD-1  and  C3H mice strains re- 
sponded to poly I- C, BALB/c mice did not. In order to further define the inter- 
strain difference in the response to synthetic ribonucleotides, poly I, poly C, and 
poly I. C were incubated with spleen cells derived from male C57B1/6J, C57B1/ 
10J, B10.D2/J, BALB/cJ, C3H/HeJ, and CBA/J mice. Spleen cells from four 
mice of each strain were cultured individually in triplicate for 24, 48,  72, and SCfiER~ STRONG, AHMED, KNUDSEN~ AND  SELL  1551 
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FIO. 3. The uptake of [3H]TdR by DBA/2N spleen cells in response to varying concentra- 
tions of poly I (Jk--A), poly C (~-II), and poly I- C (• -- •  ) at 48 h. 
96 h. The mean of the four individual  animals is expressed with  the standard 
error of all 12 cultures as shown in Fig. 6. Poly I and poly C and poly I. C stimu- 
lated  thymidine  incorporation  in  spleen  cells  from  all  of  the  mouse  strains 
studied,  although there was considerable difference in the stimulation between 
strains.  These studies support the interstrain  differences noted by Dean et al. 
(25) ; however, contrary to their findings, we did see stimulation by poly I. C in 
spleen cells from the BALB/c strain. The very low variation in the response to 
these  mitogens  among different  animals  in  the  same  strain  is  also  shown  in 
Fig. 6. 
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FIC. 4. The uptake of [3H]TdR by DBA/2N spleen cells in response to poly I (&--A), 
poly C (i--l), and poly I. C (• -- • ) at varying hours of incubation (control O--O). 
Mitogenicity of Poly I, Poly C, and Poly I.C.--In order to study the role of T 
and B  cells on the mitogen response to poly I, poly C, and poly I. C, DBA/2N 
spleen cells were incubated with either mouse anti-0 or rabbit anti-MBLA and 
rabbit complement.  Control incubations with complement and normal mouse 
and rabbit serum were run in parallel. Table I  illustrates the actions of poly I, 
poly C, poly I. C, PHA-P, Con A, and LPS on 600,000  anti-P- and complement- 
treated spleen cells. As expected, the response to PHA and Con A was reduced 
to less than control values by this treatment,  while the response to LPS was 
only slightly diminished from 93,211  to 83,481  cpm. The mitogenic response to 
poly I,  poly C,  and  poly I.C  showed  a  significant  increase  from  17,314  to 
26,328,  from 10,512  to 15,226,  and from 13,671  to 18,329  cpm, respectively, in 
the spleen cultures depleted of P-bearing cells. 
The effect of anti-MBLA treatment on responsiveness to the polynucleotides, 
PHA-P,  Con A,  and LPS,  is shown in  Table II. Anti-MBLA  treatment de- 
creased the response to LPS, poly I, poly C, and poly I. C  to levels similar to 
that  of the controls. The responses to PHA-P and  Con A  were only slightly 
decreased. 
Effect  of  Thymectomy  and  Bone Marrow  Reconstitution  on  the Response of 
C3H/tteJ Mouse Spleen Cells to Poly I, Poly C, and Poly I.C.--The ability of 
spleen cells from thymectomized, bone marrow-reconstituted (TxBM) mice to 
respond to poly I, poly C, poly I. C, PHA-P, Con A, and LPS were determined. 
There was no significant stimulation of spleen cells derived from these animals SCHER, STRONG, AHMED, KNUDSEN, AND SELL  1553 
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FIG. 5.  The uptake of [3H]TdR at 48 h by DBA/2N spleen cells in response to LPS and 
poly I.C treated with anti-lipid A or anti-poly I.C.  (a) Anti-lipid A -t- LPS (ZX--&), anti- 
poly I.C  -t- LPS  (I--I),  control NRS  +  LPS  (-I----t-).  (b) Anti-lipid A  +  poly I.C 
(/x--ZX) anti-poly I .C -I- poly I-C (I--I),  control NRS -I- poly I. C (-t----t-). 
with PHA-P concentrations ranging from 0.001  to 1%. Thus, as seen in Table 
III, depletion of T  cells in TxBM C3H/HeJ decreases the response to PHA-P 
and Con A  to control levels and increases the LPS response. The responses to 
poly I, poly C,  and poly I. C  are  also increased from 18,429 to 28,290, from 
14,259 to 20,299,  and from 16,582  to 23,698 cpm, respectively, in the TxBM 
animals when compared with sham-operated controls. When the spleens from 1,554  B-CELL ACTIVATION BY  POLYNUCLEOTIDES 
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FZG. 6.  The  uptake  of  [3HJTdR by  (a)  C57B1/10J,  (b)  C57B1/6J,  (c)  BALB/cJ,  (d) 
B10.D2/J,  (e) C3H/He[, and (f) CBA/J spleen cells in response to poly I  A--A, poly C 
m~-I, poly I. c  0-- •, and media alone O--O at various hours of incubation. 
the TxBM mice were treated with anti-~ and complement, there was no signifi- 
cant change in the response to poly I, poly C, or poly I- C  when compared with 
the  untreated  TxBM  cells. However,  after  anti-MBLA  treatment  of TxBM 
cells a marked decrease of thymidine incorporation with all mitogens tested was 
observed. 
Ability of Spleen Cells from Nu/Nu Mice to Respond to Poly I, Poly C, and 
Poly I.C.--Spleen  cells derived from Nu/Nu  mice were unable to respond to 
PHA-P in concentrations ranging from 0.001  to 1%. The response of these cells 
to the other mitogens and PHA-P at 0.05 % is shown in Table IV. No mitogenic SCHER~  STRONG~  AHM.ED~ K..NUDSEN~ AND  SELL  1555 
TABLE I 
[3H]TdR Uptake of Anti-O-Treated DBA/gn Spleen Cells in Response to Mitogens at 48 h 
Uptake of [3H]thymidine  p 
Mitogen  Concentration 
NMS treated*  Anti-O treated*  value 
cpm $ (% s~) 
Control  2,596  (4.8)  2,466  (9.0)  -- 
PHA-P  0.05%  75,065  (3.2)  1,092  (8.9)  -- 
LPS  50 /~g/ml  93,211 (1.6)  83,481  (1.5)  <0.01 
Con A  1.25 #g/ml  113,853  (8.5)  573  (15.8)  -- 
Poly I  250 #g/ml  17,314  (3.4)  " 26,328  (5..5)  <0.001 
PolyC  250#g/ml  10,512  (8.1)  15,526  (6.3)  <0.01 
Poly I.C  250 #g/ml  13,671  (3.3)  18,329  (2.6)  <0.001 
* DBA/2N spleen cells treated with anti-0 or NMS and complement and then purified by 
Ficoll-Hypaque gradient  centrifugation. 
:~ Percent standard error of triplicate  cultures. 
TABLE II 
[SH]TdR Uptake of Anti-MBLA-Treated DBA /2n Spleen Cells in Response to Mitogens at 48 h 
Mitogen  Concentration 
Uptake of [3tI]thymidine 
NRS treated*  Anti-MBLA treated* 
c~m~(% st) 
Control  2,596  (4.8)  3,374  (6.5) 
PHA-P  0.05%  78,035  (1.4)  65,698  (3.6) 
LPS  50 #g/ml  78,850  (1.7)  2,725  (11.2) 
Con A  1.25 ug/ml  94,500  (2.7)  88,283  (2.2) 
Poly I  250 #g/ml  13,857  (6.9)  4,072  (1.7) 
PolyC  250#g/ml  7,446  (4.8)  2,144  (6.0) 
Poly I.C  250 #g/ml  12,791  (2.9)  2,462  (7.6) 
* DBA/2N spleen cells treated with anti-MBLA or NRS and complement and purified by 
Ficoll-Hypaque gradient  centrifugation. 
:~ Percent standard error of triplicate  cultures. 
activity was seen with either PHA-P or Con A, whereas there was a  good re- 
sponse to LPS, poly I, poly C, and poly I. C. Treatment of the Nu/Nu  spleen 
cells with anti-0 and complement had little effect on the response to these mito- 
gens, while anti-MBLA and complement treatment reduced the responses of all 
the mitogens tested to control levels. 
Ability of Poly I, Poly C, Poly I.C,  LPS, PHA-P, and Con A  to Stimulate 
Lymphotoxin Production.--Table V  shows the levels of LT produced by DBA/ 
2N, Nu/Nu, and TxBM with PHA-P, Con A, poly I- C, and LPS. PHA-P and 
Con A  stimulated  DBA/2N spleen  cells to produce approximately equivalent 
amounts of LT with titers of 105  and 100, respectively. However, neither LPS 
nor poly I- C stimulated any detectable levels of LT in these mice. Spleen cells 1556  B-CELL  ACTIVATION  BY  POLYNUCLEOTLDES 
TABLE III 
[3tt]TdR Uptake of TxBM, TxBM +  Anti-Theta-Treated, TxBM +  Anti-MBLA- 
Treated, and Control C3H/HeJ Spleen Cells in Response to gitogem at 48 h 
Mitogen  Concentration 
Control 
PHA-P  0.05% 
LPS  50/zg/ml 
Con A  1.25  ttg/ml 
Poly I  250 #g/ml 
Poly C  250 #g/ml 
Poly I. C  250/~g/ml 
Normals* 
Uptake of [~H]thymidine 
TxBM* +  TxBM* +  anti- 
anti-0 treated  MBLA treated  TxBM* 
1,697  (5.0) 
58,881  (3.3) 
68,239  (2.2) 
64,543  (2.3) 
18,429  (3.2) 
14,295  (3.9) 
16,582  (3.6) 
7o5  (4.7) 
1,247  (8.0) 
90,775  (1.6) 
896  (2.8) 
28,290  (1.9) 
20,229  (2.6) 
23,689  (3.8) 
@m~ (% sE) 
1,076  (6.8) 
1,212  (13.8) 
128,064  (3.1) 
889  (7.2) 
29,349  (1.3) 
16,775  (5.8) 
22,864  (3.0) 
1,183  (6.6) 
1,478  (1.6) 
3,036  (15.3) 
2,116  (29.1) 
1,613  (46.3) 
1,978  (11.4) 
1,354  (29.1) 
* C3H/HeJ TxBM spleen cells were used untreated,  treated with anti-9, 
and complement and purified by Ficoll-Hypaque gradient centrifugation. 
~/Percent standard error of triplicate  cultures. 
or anti-MBLA 
TABLE IV 
[3H]TdR Uptake of Nu/Nu, Nu/Nu Anti-O-Treated amt Nu/Nu Anti-MBLA-Treated  Spleen 
Cells in Response to Mitogens at 48 h 
Mitogen  Concentration 
Uptake of [~H]thymidine 
Nu/Nu*  Nu/Nu* +  anti-  Nu/Nu* +  anti- 
theta treated  MBLA treated 
c~  (% ss) 
Control  1,228  (5.2)  961  (2.6)  584  (20.3) 
PHA-P  0.05%  1,736  (2.9)  874  (3.5)  336  (6.3) 
LPS  50/zg/ml  105,811  (3.4)  125,132  (3.0)  448  (4.9) 
ConA  1.25/zg/ml  1,564  (5.8)  744  (1.7)  346  (5.3) 
PolyI  250#g/ml  30,630  (2.4)  21,117  (4.4)  741  (3.4) 
PolyC  250#g/ml  18,290  (3.1)  16,372  (4.4)  433  (3.6) 
PolyI-C  250#g/ml  24,711  (3.8)  18,408  (2.7)  687  (2.3) 
* Nu/Nu spleen cells were used untreated,  treated with anti-0, or anti-MBLA serum and 
complement and purified by Ficoll-Hypaque gradient centrifugation. 
:~ Percent standard error of triplicate cultures. 
from nude mice (Nu/Nu) and TxBM mice failed to produce detectable levels of 
LT when incubated with any of the mitogens noted in Table V. 
DISCUSSION 
The initial reaction of lymphocytes with mitogens takes place via cell-surface re- 
ceptors (4-6, 31). The density and distribution of binding sites  on T  and B cells for 
mitogens appear to be similar  (4-6), and recent evidence suggests that lymphocyte 
activation requires that the stimulants  are at  least  divalent  (14).  Thus monomeric SCHER,  STRONG, AHMED, KNUDSEN,  AND  SELL  1557 
TABLE V 
Lymphotoxin Production by DBA/gN Spleen Cells Stimulated with Mitogens 
Mitogen  Concentration 
Reciprocal of IDa* 
DBA/2N  Nu/Nu  TxBM 
Control  0  0  0 
PHA-P  0.05%  105  0  0 
LPS  50 #g/ml  0  0  0 
Con A  1.25 #g/ml  100  0  0 
Poly I. C  250/zg/ml  0  0  0 
* The reciprocal of the dilution which shows 50% inhibition of [~H]thymidine  incorporation 
when compared with media control. 
(Fab)  anti-immunoglobulin does not alter receptor distribution  (32),  neither does it 
trigger a proliferative response (33, 34). These monomers do, however, bind to the cell 
surface; and, if they are bridged with antiglobulin, a response is induced. These results 
suggest that a critical degree of cross-linkage of receptors is obligatory for initiation 
of lymphocyte responses. It is highly probable that the same requirements are made 
of antigens since free haptens uniformly fail to activate and mono-substituted hapten- 
carrier protein conjugates bind but fail to alter receptor distribution on antihapten- 
reactive cells  (35). This requirement is also reflected in the observation that the size 
and density of antigenic determinants (14) has a profound influence on immunogenicity 
in vivo and in vitro and may provide the rationale of cell interactions in immunity. 
This interpretation focuses attention on the early cell-surface events in lymphocyte 
triggering and carries with it the implication that an effective response may relate to 
the pattern of determinant-receptor interaction (e.g. extent of cross-linkage)  (14, 36). 
The well-known ability of the thymic-independent antigen LPS to activate B cells 
(1-3) raised the question if this trait were shared by other thymic-independent anti- 
gens. It is of note that in this regard the thymic-independent antigens, SSS III and 
POL, are able to activate B cells in preliminary experiments conducted in our labora- 
tory. However, at least one thymic-independent antigen, PVP, has been suggested not 
to be a mitogenic agent (2) and this has been confirmed by us. 
Poly I. C has been shown to be a thymic-independent antigen by its ability to 
induce antibody in TxBM mice. In addition, treatment with rabbit antimouse 
thymocyte serum results in an augmented antibody response to poly I. C  (17). 
In the immune deficient CBA/HN mouse strain (37), a presumed B-cell defect 
is associated with an inability to form antibody to poly I. C (38). In this strain 
antibody to poly I. C  can be induced by complexing the polynucleotide with 
methylated bovine gamma globulin. These studies  suggest that poly I-C can 
interact with B  cells directly, inducing antibody formation without T-cell coop- 
eration. However, T  cells appear to be able to influence the formation of anti- 
body against poly I-C either by acting as suppressor cells (17), or by cooperat- 
ing with B cells when the poly I- C is complexed to a protein carrier (28, 38). 
Experiments designed to determine the role of B and T  cells in the mitogenic 1558  B-CELL  ACTIVATION  BY  POLYNUCLEOTIDES 
activity induced by poly I, poly C, and poly I- C indicated that T cells were not 
stimulated directly by these polynucleotides and that T cells were not necessary 
for B-cell activation. This conclusion was based on the response of Nu/Nu and 
C3H/HeJ  TxBM mouse spleen cells  and  anti-theta-treated DBA/2N  spleen 
cells to the three polynucleotides. The failure of PHA and Con A to stimulate 
these cultures confirmed the relative depletion of T cells. It is unlikely that small 
numbers of residual T cells could have influenced the response to poly I, poly C, 
or poly I- C in view of the inability of anti-0 and complement treatment of the 
TxBM or Nu/Nu cells to change these responses (Tables III and IV). 
Bacterial LPS contamination was not considered in the previously reported 
studies of the mitogenicity of poly I. C (25, 26). However, its presence as a con- 
taminant was a possibility in view of the bacterial source of the polyribonucleo- 
tide phosphorylase used in the preparation of the synthetic polynucleotides. The 
ability of poly I. C to act as a B-cell mitogen is central to the main theme of 
interest of this paper,  namely, that  thymic-independent antigens  other than 
LPS might also act as B-cell mitogens. The evaluation of LPS contamination of 
poly I- C was initially approached by examining poly I and poly C for mitogenic 
activity. It was reasoned that if both the poly I and poly C from which the poly 
I- C was complexed were not mitogenic, then the activity of poly I- C could not 
be secondary to LPS. That this was not the case was clearly demonstrated in 
Fig. 3, where it is shown that both poly I  and poly C are mitogenic and that 
poly I  is more stimulatory than the double-stranded poly I.C. Thus, this ap- 
proach did not answer the question of LPS contamination. Therefore, in order 
to study this problem by a different method, rabbit antibody directed against 
poly I- C was incubated with LPS and poly I. C. When the supernatant fluid of 
these  mixtures  was  assayed  for mitogenicity,  the  activity  of poly I-C  was 
abolished, while the activity of the LPS was slightly decreased (Fig. 5). This ex- 
periment does not conclusively exclude the possibility that the poly I-C was 
contaminated with LPS of a different antigenic specificity than the LPS used as 
a  mitogen in our experiments. However, reports have recently demonstrated 
that  the  mitogenic moiety of LPS  was  the  lipid  A  portion  of the  molecule 
(9, 39, 40), and it has been shown that rabbit antiserum against lipid A cross- 
reacts with lipid A from 13 different gram-negative bacteria (41). The experience 
with  the antiserum used in our studies was  similar  (unpublished data). It is 
likely, therefore, that if the mitogenic activity of poly I. C was secondary to a 
contaminating  bacterial LPS,  then  anti-lipid  A  antibody would  abolish  this 
activity. Fig. 5 demonstrates that anti-lipid A has little effect on the activity of 
poly I- C at concentrations of 25, 50, and 100/zg/ml. As expected, it abolished 
the activity of LPS. The inability of the multispecific anti-lipid A to abolish the 
mitogenic activity of poly I.C  is  strong  evidence against its  contamination 
with LPS. 
Examination of the data derived from experiments with TxBM and anti-0- 
treated spleen cells reveals a significant increase in the response to all three poly- SCtIER,  STRONG, AHMED, KNUDSEN, AND  SELL  1559 
nucleotides in these spleen cell cultures when they were compared with normal 
controls (Tables III and VI). These results could be explained by the increased 
percentage of B cells in these experiments or alternatively by the presence of a 
suppressor T  cell in the untreated control mice. If is of interest to note that 
augmentation  of the  antibody response  to  the  thymic-independent antigens 
PVP, keyhole limpet hemocyanin (KLH) (42), SSS III (43), and poly I. C (17) 
by treatment of mice with antilymphocyte serum has been shown. These studies 
have been interpreted as demonstrating the presence of T  cells  that acted to 
suppress the antibody response of B cells to these antigens. 
The difference in the mitogenicity of these polynucleotides among different 
strains is most interesting. At least  four factors could explain  the  differences 
between the inbred strains: (a) differences in the absolute numbers of B  cells 
per spleen, (b) maturational differences in B-cell function, (c) differences in the 
numbers or activity of suppressor cells, (d) differences in the ability of B cells to 
be activated or to recruit other B cells. Reported percentages of immunoglobu- 
lin-bearing spleen cells in various mouse strains have shown only small differ- 
ences between "normal" strains (44, 45). The number of B cells per spleen could 
probably not account for the strain differences noted for the mitogenicity of 
these polynucleotides. If B-cell maturation is not complete at birth and the rate 
of maturation varies between strains,  this could explain the differences in re- 
sponse to poly I, poly C, and poly I. C in these strains. In this context, it is 
interesting to note that the ability of T  cells to react to Con A (46)  and to re- 
spond in mixed lymphocyte cultures (47) does not reach maturity until 6-8 wk 
and  14-20 wk, respectively. Studies of the ability of anfithymocyte serum to 
enhance the immune response to SSS III in mice have shown differences be- 
tween strains (48). These experiments could be explained by interstrain differ- 
ences in the activity or numbers of suppressor T cells. Data regarding the ability 
of B cells to be activated or to recruit other B cells are not available. 
The data in Table V  demonstrate that both PHA-P and Con A  stimulate 
spleen cells to produce LT. Nude and TxBM mice did not produce LT in re- 
sponse to any of the mitogens. This strongly suggests that LT production is a 
property of T  cells, and the inability of LPS or poly I- C to stimulate LT pro- 
duction by these cells is further evidence that poly I- C is a B-cell mitogen. These 
data are in general agreement with those obtained by Shacks et al. (49). 
The mechanism of direct B-cell stimulation by antigens is unknown, but studies of 
flagellin by Feldmann and Basten (14) suggest that the ability of thymic-independent 
antigens  to induce antibody is related to the multivalent character of their antigenic 
determinants. In a T-cell depleted culture of mouse spleen  cells, antibody response 
to polymerized flagellin (POL) was noted, but there was no response  to monomeric 
flagellin or to flagellin-coated red cells. In non-T cell-depleted cultures,  the response 
to POL and monomeric flagellin were comparable.  It has also been shown that POL, 
when mixed with a thymic-dependent antigen and cultured with spleen cells derived 
from Nu/Nu  mice,  infuenced these  T-deprived cultures  to form antibody to  the 1560  B-CELL  ACTIVATION BY  POLYNUCLEOTIDES 
normally thymic dependent antigen (50). This ability of POL to influence B cells to 
be directly stimulated by thymic-dependent antigens has been also noted for LPS (51). 
The ability of the thymic-independent antigens poly I. C, POL, and SSS III 
to mimic the B-cell mitogenicity of LPS may be explained by the similar poly- 
meric multivalent nature of the determinants of these materials. This suggests 
that the mechanism of B-cell triggering of antibody formation to these antigens 
and their mitogenic properties might both be related to their unusual molecular 
structure. The multivalent nature  of their determinants  could act  to trigger 
specific B-cell antibody formation without T-cell cooperation under certain con- 
ditions, while under different circumstances B-cell mitogenesis could occur. Evi- 
dence for this has been demonstrated by M611er et al.  (52)  who showed that 
in order for LPS to influence T  cell-deprived animals to make antibody against 
a thymic-dependent antigen (sheep red cells),  the LPS had to be coated on the 
red cell. This property of LPS has been attributed to its ability to induce B-cell 
mitogenesis. In addition, Andersson et al. (7) have shown that the concentration 
of LPS needed to augment the B-cell response to an unrelated antigen and to 
induce B-cell mitogenesis was 10-100 times greater than that required for spe- 
cific antibody formation. These studies and the inability of the thymic-inde- 
pendent antigen PVP to induce B-cell mitogenesis indicate that although the 
molecular structure  of thymic-independent antigens  are  important for their 
antigenicity, other factors are also necessary for B-cell mitogenesis. 
SUMMARY 
The synthetic single-  and double-stranded polynucleotides, poly I, poly  C, 
and  poly I. C,  were  shown  to induce  thymidine incorporation in  six  inbred 
strains of murine spleen cells.  This stimulation was shown to be secondary to 
B-cell activation and not due  to  contamination of the polynucleotides with 
bacterial lipopolysaccharide (LPS). The ability of poly I-C to act as a B-cell 
mitogen, in addition to its behavior as a thymic-independent antigen, suggested 
that these two phenomena may be related. The similarity of the molecular struc- 
ture of poly I. C  to LPS, a material which also acts as a thymic-independent 
antigen and a B-cell mitogen, supports the hypothesis that the polyvalent na- 
ture of these materials accounts for their functional interaction with murine B 
cells. 
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